Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 3512: Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia

View through CrossRef
Abstract B-Cell CLL/Lymphoma 6 (BCL6) is a proto-oncogene that is highly expressed in acute lymphoblastic leukemia (ALL). BTB and CNC Homology 1 Basic Leucine Zipper Transcription Factor 2 (BACH2) is a suppressor of transcription. The BACH2-BCL6 balance controls selection at the pre-B cell receptor checkpoint by regulating p53 expression. However, the underlying mechanism and the clinical relevance of the BCL6/BACH2 axis are unknown. Here, we found that Ikaros, a tumor suppressor encoded by IKZF1, directly binds to both the BCL6 and BACH2 promoters where it suppresses BCL6 and promotes BACH2 expression in B-cell ALL (B-ALL) cells. Casein kinase 2 (CK2) inhibitors increase Ikaros function thereby inhibiting BCL6 and promoting BACH2 expression in an Ikaros-dependent manner. We also found that the expression of BCL6 is higher while BACH2 expression is lower in patients with B-ALL than normal bone marrow control. High BCL6 and low BACH2 expression is associated with high leukemic cell proliferation, unfavorable clinical and laboratory features, and inferior outcomes. Moreover, IKZF1 deletion is associated with high BCL6 and low BACH2 expression in B-ALL patients. CK2 inhibitors increase Ikaros binding to the promoter of BCL6 and BACH2 and suppress BCL6 while promoting BACH2 expression in the primary B-ALL cells. Our data indicates that Ikaros regulates expression of the BCL6/BACH2 axis in B-ALL. High BCL6 and low BACH2 expression are associated with Ikaros dysregulation and have a potential effect on the development of B-ALL. Citation Format: Chunhua Song, Zheng Ge, Jianyong Li, Baoan Chen, Elanora Dovat, Katarina Dovat, Jonathon Payne, Sinisa Dovat. Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3512. doi:10.1158/1538-7445.AM2017-3512
Title: Abstract 3512: Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia
Description:
Abstract B-Cell CLL/Lymphoma 6 (BCL6) is a proto-oncogene that is highly expressed in acute lymphoblastic leukemia (ALL).
BTB and CNC Homology 1 Basic Leucine Zipper Transcription Factor 2 (BACH2) is a suppressor of transcription.
The BACH2-BCL6 balance controls selection at the pre-B cell receptor checkpoint by regulating p53 expression.
However, the underlying mechanism and the clinical relevance of the BCL6/BACH2 axis are unknown.
Here, we found that Ikaros, a tumor suppressor encoded by IKZF1, directly binds to both the BCL6 and BACH2 promoters where it suppresses BCL6 and promotes BACH2 expression in B-cell ALL (B-ALL) cells.
Casein kinase 2 (CK2) inhibitors increase Ikaros function thereby inhibiting BCL6 and promoting BACH2 expression in an Ikaros-dependent manner.
We also found that the expression of BCL6 is higher while BACH2 expression is lower in patients with B-ALL than normal bone marrow control.
High BCL6 and low BACH2 expression is associated with high leukemic cell proliferation, unfavorable clinical and laboratory features, and inferior outcomes.
Moreover, IKZF1 deletion is associated with high BCL6 and low BACH2 expression in B-ALL patients.
CK2 inhibitors increase Ikaros binding to the promoter of BCL6 and BACH2 and suppress BCL6 while promoting BACH2 expression in the primary B-ALL cells.
Our data indicates that Ikaros regulates expression of the BCL6/BACH2 axis in B-ALL.
High BCL6 and low BACH2 expression are associated with Ikaros dysregulation and have a potential effect on the development of B-ALL.
Citation Format: Chunhua Song, Zheng Ge, Jianyong Li, Baoan Chen, Elanora Dovat, Katarina Dovat, Jonathon Payne, Sinisa Dovat.
Ikaros regulation of the BCL6/BACH2 axis and its clinical relevance in acute lymphoblastic leukemia [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3512.
doi:10.
1158/1538-7445.
AM2017-3512.

Related Results

Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
The IKZF1 gene encodes the Ikaros protein that acts as a tumor suppressor in acute lymphoblastic leukemia (ALL). The role of Ikaros in T‐cell acute lymphoblastic leukemia (T‐ALL) h...
Epigenetic Regulation of Oncogenes in Leukemia by the Ikaros Tumor Suppressor
Epigenetic Regulation of Oncogenes in Leukemia by the Ikaros Tumor Suppressor
The IKZF1 gene controls expression of the Ikaros protein which functions as a tumor suppressor in pediatric acute lymphoblastic leukemia (ALL). Dysfunction of Ikaros due to deletio...
Abstract 3504: Regulation of cell cycle progression by Ikaros in leukemia
Abstract 3504: Regulation of cell cycle progression by Ikaros in leukemia
Abstract Control of cell cycle progression is achieved by the coordinated function of a large set of genes that are highly conserved in eukaryotic organisms. Maligna...
Repression of the Pontin (RUVBL1, TIP49) Gene By BCL6: Implications for the Pathogenesis of Human B and T Cell Lymphomas
Repression of the Pontin (RUVBL1, TIP49) Gene By BCL6: Implications for the Pathogenesis of Human B and T Cell Lymphomas
Abstract The human BCL6 gene encodes a transcriptional repressor that is needed for germinal center B cell development and T follicular helper cell differentiation, ...
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Ikaros encodes a DNA binding protein that regulates gene expression via chromatin remodeling and epigenetic mechanisms. The loss of Ikaros activity due to genetic or functional ina...
Use of qChIP to identify genes targeted by the Ikaros tumor suppressor
Use of qChIP to identify genes targeted by the Ikaros tumor suppressor
The IKAROS gene encodes a DNA binding zinc finger protein that is essential for hematopoietic differentiation and acts as a tumor suppressor in leukemia. The Ikaros protein is know...
Characterization of the DNA binding of Ikaros protein using three dimensional modeling and rapid prototyping technology
Characterization of the DNA binding of Ikaros protein using three dimensional modeling and rapid prototyping technology
Human hematopoiesis is controlled by the coordinated activity of various genes. The Ikaros gene encodes a DNA‐binding protein that is essential for normal hematopoiesis and acts as...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...

Back to Top